Q32 Bio Statistics
Total Valuation
Q32 Bio has a market cap or net worth of $20.86 million. The enterprise value is -$38.21 million.
Important Dates
The last earnings date was Tuesday, March 11, 2025, before market open.
| Earnings Date | Mar 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Q32 Bio has 12.20 million shares outstanding. The number of shares has increased by 2,666.77% in one year.
| Current Share Class | 12.20M |
| Shares Outstanding | 12.20M |
| Shares Change (YoY) | +2,666.77% |
| Shares Change (QoQ) | +0.86% |
| Owned by Insiders (%) | 0.62% |
| Owned by Institutions (%) | 31.62% |
| Float | 4.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.68 |
| P/TBV Ratio | 3.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.97, with a Debt / Equity ratio of 3.33.
| Current Ratio | 4.97 |
| Quick Ratio | 4.77 |
| Debt / Equity | 3.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -47.22 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -59.28% |
| Return on Invested Capital (ROIC) | -2,097.14% |
| Return on Capital Employed (ROCE) | -87.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.11M |
| Employee Count | 43 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Q32 Bio has paid $21,000 in taxes.
| Income Tax | 21,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.42% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -89.42% |
| 50-Day Moving Average | 2.59 |
| 200-Day Moving Average | 23.79 |
| Relative Strength Index (RSI) | 28.58 |
| Average Volume (20 Days) | 151,570 |
Short Selling Information
The latest short interest is 1.01 million, so 8.27% of the outstanding shares have been sold short.
| Short Interest | 1.01M |
| Short Previous Month | 1.03M |
| Short % of Shares Out | 8.27% |
| Short % of Float | 21.33% |
| Short Ratio (days to cover) | 4.37 |
Income Statement
| Revenue | n/a |
| Gross Profit | -48.14M |
| Operating Income | -66.10M |
| Pretax Income | -65.02M |
| Net Income | -47.73M |
| EBITDA | -65.62M |
| EBIT | -66.10M |
| Earnings Per Share (EPS) | -$6.58 |
Full Income StatementBalance Sheet
The company has $77.97 million in cash and $18.90 million in debt, giving a net cash position of $59.06 million or $4.84 per share.
| Cash & Cash Equivalents | 77.97M |
| Total Debt | 18.90M |
| Net Cash | 59.06M |
| Net Cash Per Share | $4.84 |
| Equity (Book Value) | 5.68M |
| Book Value Per Share | 0.47 |
| Working Capital | 65.41M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$67.72 million and capital expenditures -$75,000, giving a free cash flow of -$67.79 million.
| Operating Cash Flow | -67.72M |
| Capital Expenditures | -75,000 |
| Free Cash Flow | -67.79M |
| FCF Per Share | -$5.56 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |